vs

Side-by-side financial comparison of STEPAN CO (SCL) and Verisign (VRSN). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $425.3M, roughly 1.4× Verisign). Verisign runs the higher net margin — 48.5% vs 3.3%, a 45.2% gap on every dollar of revenue. On growth, Verisign posted the faster year-over-year revenue change (7.6% vs 1.9%). Over the past eight quarters, Verisign's revenue compounded faster (5.2% CAGR vs 4.2%).

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

SCL vs VRSN — Head-to-Head

Bigger by revenue
SCL
SCL
1.4× larger
SCL
$604.5M
$425.3M
VRSN
Growing faster (revenue YoY)
VRSN
VRSN
+5.7% gap
VRSN
7.6%
1.9%
SCL
Higher net margin
VRSN
VRSN
45.2% more per $
VRSN
48.5%
3.3%
SCL
Faster 2-yr revenue CAGR
VRSN
VRSN
Annualised
VRSN
5.2%
4.2%
SCL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
SCL
SCL
VRSN
VRSN
Revenue
$604.5M
$425.3M
Net Profit
$19.7M
$206.2M
Gross Margin
10.7%
88.5%
Operating Margin
4.7%
67.0%
Net Margin
3.3%
48.5%
Revenue YoY
1.9%
7.6%
Net Profit YoY
7.7%
EPS (diluted)
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SCL
SCL
VRSN
VRSN
Q1 26
$604.5M
Q4 25
$553.9M
$425.3M
Q3 25
$590.3M
$419.1M
Q2 25
$594.7M
$409.9M
Q1 25
$593.3M
$402.3M
Q4 24
$525.6M
$395.4M
Q3 24
$546.8M
$390.6M
Q2 24
$556.4M
$387.1M
Net Profit
SCL
SCL
VRSN
VRSN
Q1 26
$19.7M
Q4 25
$5.0M
$206.2M
Q3 25
$10.8M
$212.8M
Q2 25
$11.3M
$207.4M
Q1 25
$19.7M
$199.3M
Q4 24
$3.4M
$191.5M
Q3 24
$23.6M
$201.3M
Q2 24
$9.5M
$198.8M
Gross Margin
SCL
SCL
VRSN
VRSN
Q1 26
10.7%
Q4 25
9.3%
88.5%
Q3 25
12.0%
88.4%
Q2 25
12.1%
88.0%
Q1 25
12.7%
87.7%
Q4 24
10.8%
87.8%
Q3 24
13.8%
88.0%
Q2 24
12.5%
87.8%
Operating Margin
SCL
SCL
VRSN
VRSN
Q1 26
4.7%
Q4 25
1.9%
67.0%
Q3 25
3.7%
67.8%
Q2 25
3.0%
68.5%
Q1 25
4.8%
67.4%
Q4 24
1.5%
66.7%
Q3 24
4.4%
68.9%
Q2 24
3.4%
68.8%
Net Margin
SCL
SCL
VRSN
VRSN
Q1 26
3.3%
Q4 25
0.9%
48.5%
Q3 25
1.8%
50.8%
Q2 25
1.9%
50.6%
Q1 25
3.3%
49.5%
Q4 24
0.6%
48.4%
Q3 24
4.3%
51.5%
Q2 24
1.7%
51.4%
EPS (diluted)
SCL
SCL
VRSN
VRSN
Q1 26
$0.86
Q4 25
$0.22
Q3 25
$0.47
Q2 25
$0.50
Q1 25
$0.86
Q4 24
$0.14
Q3 24
$1.03
Q2 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SCL
SCL
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$580.5M
Total DebtLower is stronger
$328.4M
Stockholders' EquityBook value
$1.2B
$-2.2B
Total Assets
$2.3B
$1.3B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
$132.7M
$580.5M
Q3 25
$118.5M
$617.7M
Q2 25
$88.9M
$593.8M
Q1 25
$107.5M
$648.5M
Q4 24
$99.7M
$599.9M
Q3 24
$147.3M
$644.9M
Q2 24
$124.7M
$689.9M
Total Debt
SCL
SCL
VRSN
VRSN
Q1 26
$328.4M
Q4 25
$626.7M
Q3 25
$655.5M
Q2 25
$658.0M
Q1 25
$659.3M
Q4 24
$625.4M
Q3 24
$688.5M
Q2 24
$657.1M
Stockholders' Equity
SCL
SCL
VRSN
VRSN
Q1 26
$1.2B
Q4 25
$1.2B
$-2.2B
Q3 25
$1.2B
$-2.1B
Q2 25
$1.2B
$-2.0B
Q1 25
$1.2B
$-2.0B
Q4 24
$1.2B
$-2.0B
Q3 24
$1.2B
$-1.9B
Q2 24
$1.2B
$-1.8B
Total Assets
SCL
SCL
VRSN
VRSN
Q1 26
$2.3B
Q4 25
$2.4B
$1.3B
Q3 25
$2.4B
$1.4B
Q2 25
$2.4B
$1.4B
Q1 25
$2.4B
$1.4B
Q4 24
$2.3B
$1.4B
Q3 24
$2.4B
$1.5B
Q2 24
$2.3B
$1.5B
Debt / Equity
SCL
SCL
VRSN
VRSN
Q1 26
0.28×
Q4 25
0.50×
Q3 25
0.53×
Q2 25
0.53×
Q1 25
0.55×
Q4 24
0.53×
Q3 24
0.56×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SCL
SCL
VRSN
VRSN
Operating Cash FlowLast quarter
$289.6M
Free Cash FlowOCF − Capex
$285.1M
FCF MarginFCF / Revenue
67.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
$60.0M
$289.6M
Q3 25
$69.8M
$307.7M
Q2 25
$11.2M
$202.5M
Q1 25
$6.9M
$291.3M
Q4 24
$68.3M
$231.5M
Q3 24
$22.7M
$253.4M
Q2 24
$29.5M
$160.4M
Free Cash Flow
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
$25.4M
$285.1M
Q3 25
$40.2M
$303.0M
Q2 25
$-14.4M
$194.7M
Q1 25
$-25.8M
$285.5M
Q4 24
$32.1M
$222.0M
Q3 24
$-4.0M
$247.8M
Q2 24
$-208.0K
$151.2M
FCF Margin
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
4.6%
67.0%
Q3 25
6.8%
72.3%
Q2 25
-2.4%
47.5%
Q1 25
-4.3%
71.0%
Q4 24
6.1%
56.1%
Q3 24
-0.7%
63.4%
Q2 24
-0.0%
39.1%
Capex Intensity
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
6.3%
1.1%
Q3 25
5.0%
1.1%
Q2 25
4.3%
1.9%
Q1 25
5.5%
1.4%
Q4 24
6.9%
2.4%
Q3 24
4.9%
1.4%
Q2 24
5.3%
2.4%
Cash Conversion
SCL
SCL
VRSN
VRSN
Q1 26
Q4 25
11.99×
1.40×
Q3 25
6.44×
1.45×
Q2 25
0.99×
0.98×
Q1 25
0.35×
1.46×
Q4 24
20.38×
1.21×
Q3 24
0.96×
1.26×
Q2 24
3.10×
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

VRSN
VRSN

Segment breakdown not available.

Related Comparisons